Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis.
Gasparri ML, Albasini S, Truffi M, Favilla K, Tagliaferri B, Piccotti F, Bossi D, Armatura G, Calcinotto A, Chiappa C, Combi F, Curcio A, Della Valle A, Ferrari G, Folli S, Ghilli M, Listorti C, Mancini S, Marinello P, Mele S, Pertusati A, Roncella M, Rossi L, Rovera F, Segattini S, Sgarella A, Tognali D, Corsi F. Gasparri ML, et al. Among authors: tagliaferri b. Ther Adv Med Oncol. 2023 Sep 15;15:17588359231193732. doi: 10.1177/17588359231193732. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37720495 Free PMC article.
Patterns of treatment and outcome with 500-mg fulvestrant in postmenopausal women with hormone receptor-positive/HER2-negative metastatic breast cancer: a real-life multicenter Italian experience.
Palumbo R, Sottotetti F, Quaquarini E, Gambaro A, Ferzi A, Tagliaferri B, Teragni C, Licata L, Serra F, Lapidari P, Bernardo A. Palumbo R, et al. Among authors: tagliaferri b. Ther Adv Med Oncol. 2019 Jun 4;11:1758835919833864. doi: 10.1177/1758835919833864. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 31210797 Free PMC article.
Role of androgen receptor expression in early stage ER+/PgR-/HER2- breast cancer.
Tagliaferri B, Quaquarini E, Palumbo R, Balletti E, Presti D, Malovini A, Agozzino M, Teragni CM, Terzoni A, Bernardo A, Villani L, Sottotetti F. Tagliaferri B, et al. Ther Adv Med Oncol. 2020 Sep 17;12:1758835920958355. doi: 10.1177/1758835920958355. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32994808 Free PMC article.
Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study.
Palumbo R, Torrisi R, Sottotetti F, Presti D, Rita Gambaro A, Collovà E, Ferzi A, Agostinetto E, Maria Teragni C, Saltalamacchia G, Tagliaferri B, Balletti E, Bernardo A, Quaquarini E. Palumbo R, et al. Among authors: tagliaferri b. Ther Adv Med Oncol. 2021 Mar 10;13:1758835920987651. doi: 10.1177/1758835920987651. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33796150 Free PMC article.
Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy.
Sevieri M, Andreata F, Mainini F, Signati L, Piccotti F, Truffi M, Bonizzi A, Sitia L, Pigliacelli C, Morasso C, Tagliaferri B, Corsi F, Mazzucchelli S. Sevieri M, et al. Among authors: tagliaferri b. J Nanobiotechnology. 2024 Apr 15;22(1):184. doi: 10.1186/s12951-024-02441-4. J Nanobiotechnology. 2024. PMID: 38622644 Free PMC article.
Publisher Correction: Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy.
Sevieri M, Andreata F, Mainini F, Signati L, Piccotti F, Truffi M, Bonizzi A, Sitia L, Pigliacelli C, Morasso C, Tagliaferri B, Corsi F, Mazzucchelli S. Sevieri M, et al. Among authors: tagliaferri b. J Nanobiotechnology. 2024 May 27;22(1):288. doi: 10.1186/s12951-024-02532-2. J Nanobiotechnology. 2024. PMID: 38797820 Free PMC article. No abstract available.
Breast cancer patient-derived organoids for the investigation of patient-specific tumour evolution.
Mazzucchelli S, Signati L, Messa L, Franceschini A, Bonizzi A, Castagnoli L, Gasparini P, Consolandi C, Mangano E, Pelucchi P, Cifola I, Camboni T, Severgnini M, Villani L, Tagliaferri B, Carelli S, Pupa SM, Cereda C, Corsi F. Mazzucchelli S, et al. Among authors: tagliaferri b. Cancer Cell Int. 2024 Jun 27;24(1):220. doi: 10.1186/s12935-024-03375-5. Cancer Cell Int. 2024. PMID: 38926706 Free PMC article.
50 results